Lexylan » LABIANA Group

Labiana adds a new injectable antibiotic to its portfolio with 0 days withdrawal time in milk (dairy cow)

Labiana | 25 March

Labiana, the pharmaceutical laboratory specialized in animal and human health listed on BME Growth, has added Lexylan, a new antibiotic classified as Category C in its prescription guidelines, to its product portfolio.